Jump to ContentJump to Main Navigation
A Decade of HAARTThe Development and Global Impact of Highly Active Antiretroviral Therapy
Users without a subscription are not able to see the full content.

A Decade of HAART: The Development and Global Impact of Highly Active Antiretroviral Therapy

José M. Zuniga, Alan Whiteside, Amin Ghaziani, and John G. Bartlett

Abstract

Highly active antiretroviral therapy (HAART) is a therapeutic intervention developed by clinicians and researchers in order to fight the HIV pandemic. It has contributed to a significant reduction in AIDS-related mortality and allowed many previously bed-ridden patients to live healthier, more productive lives. Until the advent of HAART in 1996, a diagnosis of HIV infection was considered a death sentence. A decade later, the disease has been transformed into a serious, yet potentially manageable, medical condition for thousands of people living with HIV/AIDS in the developed world — almost ov ... More

Keywords: HAART, HIV, AIDS, highly active antiretroviral therapy, HIV treatment

Bibliographic Information

Print publication date: 2008 Print ISBN-13: 9780199225859
Published to Oxford Scholarship Online: September 2009 DOI:10.1093/acprof:oso/9780199225859.001.0001

Authors

Affiliations are at time of print publication.

José M. Zuniga, editor
President/CEO, International Association of Physicians in AIDS Care, Chicago, USA

Alan Whiteside, editor
Director, Health and Economics and HIV/AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban, South Africa

Amin Ghaziani, editor
Cotsen Postdoctoral Fellow, Society of Fellows, Princeton University, USA

More
Show Summary Details

subscribe or login to access all content.

Subscriber Login

Forgotten your password?

Contents

View:

Part 1 A decade of HAART: trials, tribulations and successes

Chapter 1 Introduction

José M. Zuniga*, Alan Whiteside, Amin Ghaziani and John G. Bartlett

Chapter 2 A world ravaged by a disease without HAART

José M. Zuniga* and Amin Ghaziani

Chapter 4 The outcome and impact of 10 years of HAART

Eduard J. Beck* and Rochelle P. Walensky

Chapter 5 HAART in HIV-infected children: one decade later

Arry Dieudonne*, James A. McIntyre, Federica Fregonese, Carlo Giaquinto and James M. Oleske

Part 2 HAART in high human development countries

Chapter 6 Country review: Australia

Kathleen Glenday, Kathy Petoumenos*, Matthew G. Law and David A. Cooper

Chapter 8 Country review: Germany

Eva Wolf* and Hans Jaeger

Chapter 11 US Cohorts review: The HIV Outpatient Study (HOPS) and the Multicenter AIDS Cohort Study (MACS)

Frank J. Palella, Jr*, Anne C. Moorman, John T. Brooks (HOPS)l; John Phair*, Lisa Jacobson, Roger Detels, Joseph Margolick and Charles Rinaldo (MACS)

Chapter 14 The Swiss HIV Cohort Study (SHCS)

Huldrych F. Günthard and Bernard Hirschel*

Part 3 HAART in medium human development countries

Chapter 16 Country review: Brazil

Celso Ferreira Ramos-Filho* and Cledy Eliana dos Santos

Chapter 17 Country review: China

Zhang Fu-Jie*, Ray Y. Chen, Selina N. Lo and Ma Ye

Chapter 18 Country review: South Africa

Robin Wood* and Des Martin

Chapter 19 Country review: Thailand

Praphan Phanuphak*, Sanchai Chasombat and Jintanat Ananworanich

Chapter 20 Cohort studies in Brazil: Projeto Praça Onze

Mauro Schechter* and Suely Hiromi Tuboi

Part 4 HAART in low human development countries

Chapter 22 Country review: Haiti

Serena Koenig*, Julia Carney, Peter Bendix and Jean William Pape

Chapter 23 Country review: Malawi

Erik J. Schouten*, Simon D. Makombe, Anthony D. Harries and Kelita Kamoto

Chapter 25 Country review: Zambia

Moses Sinkala and Benjamin H. Chi*

Part 5 Future challenges in the next decade of HAART

Chapter 26 The clinical challenges of lifetime HAART

Roger Paredes*, Renslow Sherer and Bonaventura Clotet

Chapter 28 Redefining HIV/AIDS care delivery in the face of human resource scarcity

Mario Roberto Dal Poz*, Norbert Dreesch and Dingie van Rensburg

End Matter